Daraxonrasib

Daraxonrasib is an investigational new drug being developed by Revolution Medicines and evaluated for the treatment of solid tumours. It is an orally administered small molecule pan-RAS inhibitor. The... Wikipedia

• Pronunciation:  -son -ib]]
• CAS Number:  2765081-21-6
• ATC code:  None
• PubChem:  CID [/pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=164726578 164726578]
• IUPHAR/BPS:  13368
• ChemSpider:  115275938
• UNII:  B6T47Y2UAP
• KEGG:  D13265
• ChEBI:  CHEBI:746946
• Synonyms:  RMC-6236
• Data source:  DuckDuckGo